Qian Zhang

机构：Hebei Medical University, Shandong University of Technology, Schlumberger (British Virgin Islands), Shanxi Medical University, National Clinical Research Center for Digestive Diseases, Second Hospital of Shanxi Medical University, Hospice UK, The Patients Association, Shanxi Cardiovascular Hospital, Huazhong University of Science and Technology, Nanjing Medical University · ORCID：0000-0003-1053-1588

发表论文 49 篇 · 总被引 810 次 · h-index 15

代表论文

• Non-alcoholic fatty liver is associated with increased risk of irritable bowel syndrome: a prospective cohort study (2022 · BMC Medicine · 被引 44)
• Small Antibodies with Big Applications: Nanobody-Based Cancer Diagnostics and Therapeutics (2023 · Cancers · 被引 28)
• Paeoniflorin-free subfraction of Paeonia lactiflora Pall. shows the potential of anti-hepatic fibrosis: an integrated analysis of network pharmacology and experimental validation (2022 · Journal of Ethnopharmacology · 被引 20)
• Relationship between controlled attenuated parameter and magnetic resonance imaging–proton density fat fraction for evaluating hepatic steatosis in patients with NAFLD (2022 · Hepatology Communications · 被引 16)
• CS27109, A Selective Thyroid Hormone Receptor-β Agonist Alleviates Metabolic-Associated Fatty Liver Disease in Murine Models (2023 · International Journal of Endocrinology · 被引 11)
• Associations of Combined Lifestyle Factors with MAFLD and the Specific Subtypes in Middle-Aged and Elderly Adults: The Dongfeng-Tongji Cohort Study (2023 · Nutrients · 被引 9)